Onyx Equities and Machine Investment Group have acquired the Northeast Science and Technology (NEST) Center, a research and development campus in New Jersey from Merck. Located at 2000 Galloping Hill Road, the campus spans over 2 million square feet with potential to become a hub of innovation for life sciences and biotechnology industries. The NEST Center boasts 1.4 million square feet of laboratory buildings, 30 acres of redevelopment opportunities, 500,000 square feet of Class-A office space as well as utility infrastructure and various amenities.
John Saraceno – co-founder & managing partner at NEST Center – commented on the acquisition: “The biotechnology industry has an immense demand for both turnkey & customizable solutions; prior to NEST many health tech companies were forced to wait years for adequate laboratory & workspace which hindered their progress towards finding cures” He added that “Nest allows those on cutting edge medicine to focus solely on their work rather than worrying about an office location” This acquisition will provide much needed resources in order facilitate growth within life sciences & biotech sectors while allowing innovators access to modern facilities without long wait times or other obstacles they may face when searching for suitable locations
